Biosynthetic Pathway for Furanosteroid Demethoxyviridin and Identification

Total Page:16

File Type:pdf, Size:1020Kb

Biosynthetic Pathway for Furanosteroid Demethoxyviridin and Identification ARTICLE DOI: 10.1038/s41467-018-04298-2 OPEN Biosynthetic pathway for furanosteroid demethoxyviridin and identification of an unusual pregnane side-chain cleavage Gao-Qian Wang1, Guo-Dong Chen1, Sheng-Ying Qin2, Dan Hu 1, Takayoshi Awakawa3, Shao-Yang Li1, Jian-Ming Lv1, Chuan-Xi Wang 1, Xin-Sheng Yao1, Ikuro Abe 3 & Hao Gao 1 1234567890():,; Furanosteroids, represented by wortmannin, viridin, and demethoxyviridin, are a special group of fungal-derived, highly oxygenated steroids featured by an extra furan ring. They are well-known nanomolar-potency inhibitors of phosphatidylinositol 3-kinase and widely used in biological studies. Despite their importance, the biosyntheses of these molecules are poorly understood. Here, we report the identification of the biosynthetic gene cluster for demethoxyviridin, consisting of 19 genes, and among them 15 biosynthetic genes, including six cytochrome P450 monooxygenase genes, are deleted. As a result, 14 biosynthetic intermediates are isolated, and the biosynthetic pathway for demethoxyviridin is elucidated. Notably, the pregnane side-chain cleavage requires three enzymes: flavin-dependent Baeyer-Villiger monooxygenase, esterase, and dehydrogenase, in sharp contrast to the single cytochrome P450-mediated process in mammalian cells. Structure–activity analyses of these obtained biosynthetic intermediates reveal that the 3-keto group, the C1β–OH, and the aromatic ring C are important for the inhibition of phosphatidylinositol 3-kinase. 1 Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, 510632 Guangzhou, People’s Republic of China. 2 Clinical Experimental Center, First Affiliated Hospital of Jinan University, 510630 Guangzhou, People’s Republic of China. 3 Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 HongoBunkyo-kuTokyo 113-0033, Japan. These authors contributed equally: Gao-Qian Wang, Guo-Dong Chen, Sheng-Ying Qin. Correspondence and requests for materials should be addressed to D.H. (email: [email protected]) or to I.A. (email: [email protected]) or to H.G. (email: [email protected]) NATURE COMMUNICATIONS | (2018) 9:1838 | DOI: 10.1038/s41467-018-04298-2 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04298-2 teroids are modified triterpenoids containing the tetracyclic further insight into the biosynthesis of demethoxyviridin from system of lanosterol, but lacking the three methyl groups at lanosterol, Hanson et al. identified a group of ergosterol side- S fi C4 and C14. Further modi cations in the side chain lead to chain-derived C6 and C7 alcohols sharing a common origin with – different sub-classes of steroids bearing C18 C29 skeletons. They demethoxyviridin. This suggested that the removal of the sterol are some of the most widely distributed small molecules in nature side chain during demethoxyviridin biosynthesis occurs between and serve a myriad of biological functions. Sterols are the most C20 and C22, in a pathway analogous to the sterol side-chain important form of steroids, with a hydroxyl group at C3 and a cleavage during the biosynthesis of steroid hormones in mam- skeleton derived from cholestane, among which cholesterol in malian cells18, 19. Despite these advances, the genetic basis for the animals, sitosterol in plants, and ergosterol in fungi are well- biosynthesis of furanosteroids has remained elusive. Recently, a known molecules, as they are the essential components of the transcriptional comparison of Trichoderma virens IMI 304061, a cellular membranes in these eukaryotic organisms1, 2. In addition, high producer of viridin, and its mutant strain deficient in sec- sterols are important precursors for many biologically important ondary metabolite production identified a four-gene cluster pre- molecules, such as the steroid hormones from animals and the dicted to be responsible for the biosynthesis of viridin;20 however, cardenolides from plants, by extensive carbon degradation3, 4.In it was soon realized that this gene cluster is involved in the fungi, the oxidative removal of carbons from sterol precursors biosynthesis of volatile terpene compounds, rather than viridin21. also produces active molecules, such as wortmannin, viridin, and During our manuscript submission, Bansal et al. reported a demethoxyviridin (1), which are called furanosteroids because all biosynthetic gene cluster for viridin, but they did not provide of these molecules contain an extra furan ring fused between C4 substantial evidence for the biosynthetic pathway of viridin22. and C6 of the steroidal framework (Fig. 1a)5. Since viridin was In our previous explorations for bioactive secondary first discovered in 19456, extensive biological studies of this class metabolites from fungi23, 24, we identified the endolichenic fungus of compounds have been performed, which revealed that Nodulisporium sp. (no. 65-12-7-1), which can produce large furanosteroids possess a variety of important biological proper- amounts of demethoxyviridin (1) and several analogs25, 26. These ties, including antifungal, anti-inflammatory, and antibacterial findings provided a good chance to elucidate its biosynthesis. activities7, 8. Especially, furanosteroids are nanomolar-potency Here, we report the identification of the gene cluster and the inhibitors of phosphatidylinositol 3-kinase (PI3K), among which biosynthetic pathway for 1, by the combinational use of a wortmannin has been developed as a commercial PI3K inhibitor transcriptome comparison analysis, CRISPR-Cas9-based gene widely used in various biological studies9, 10. Notably, a semi- disruption, an Aspergillus oryzae NSAR1 heterologous gene synthetic analog of wortmannin, PX-866, was tested in a phase II expression system, and an in vitro enzymatic assay. Our study clinical trial for treating cancers11. The intriguing structures and sets the stage to uncover the biosyntheses of other furanosteroids excellent biological activities of furanosteroids have thus led to and expands the chemical diversity of pharmaceutically impor- extensive efforts toward their total chemical synthesis over the tant furanosteroids by engineered biosyntheses. past 20 years, and the stereoselective synthesis of wortmannin and (–)-viridin was finally achieved in 201712, 13. However, as compared with the progress in chemical synthesis, the bio- Results synthesis of these important molecules in fungi is poorly Identification of the gene cluster for demethoxyviridin. understood. Although in most cases, terpene cyclase is often clustered with its Early isotope labeling experiments with 13C-labeled mevalo- downstream modification enzymes in fungal genomes27, the nate or acetate revealed that viridin, demethoxyvridin, and lanosterol-derived triterpenes/steroids, including ergosterol and wortmannin are formed from two farnesyl units in a steroid-like ganoderic acid, do not conform to this rule28, 29. This could be the – manner, and do not originate from a diterpenoid14 16.A reason why Kenerley et al. failed to find the biosynthetic gene subsequent study using 14C-labeled lanosterol confirmed that it is cluster of viridin, when using terpene cyclase as the starting converted to viridin via a normal steroidal pathway17. To gain point21. Therefore, a different strategy based on other features of a O O O MeO AcO OH OH C D MeO O A B H O 4 E 6 O O O O O O O O Wortmannin Viridin Demethoxyviridin (1) b vidA vidB vidC vidD vidE vidF vidG vidH vidI vidJ vidK vidL vidM vidN vidO vidP vidQ vidR vidS 42.7 kb CYP BVFMO Unknown Transporter Dehydrogenase Esterase Bet v1-like protein Oxidoreductase Glyoxalase I Demethoxyviridin biosynthetic gene cluster from Nodulisporium sp. (No. 65-12-7-1) Fig. 1 Representative furanosteroids and biosynthetic gene cluster of demethoxyviridin (1). a Structures of wortmannin, viridin, and demethoxyviridin (1). b Gene map of the demethoxyviridin biosynthetic gene cluster from Nodulisporium sp. (no. 65-12-7-1), consisting of 19 genes from vidA (g3266)tovidS (g3284). The arrow indicates the direction from the start to the stop codon. Different types of genes are indicated by different colors and among them red arrows indicate six CYP genes 2 NATURE COMMUNICATIONS | (2018) 9:1838 | DOI: 10.1038/s41467-018-04298-2 | www.nature.com/naturecommunications NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04298-2 ARTICLE ELSD 12 O O O a q 11 13 1 OH 17 2 19 OH JN1001(wt) 1 14 10 8 15 3 O 7 O b 4 3 4 6 HO O O O ΔvidK 29 O O O 132 c 6 7 5 ΔvidA d 8 6 O O O ΔvidD 7 e 8 Δ H H vidH HO O HO O HO O O O O 9 f ΔvidP 4 56 g 11 10 12 ΔvidF OH OH O O h 13 Δ vidS H H H O O HO O HO O 14 O O O i ΔvidQ 7 89 j 2 ΔvidJ O O O 1 20 k ΔvidM O H H HO H O O HO O HO l ΔvidE O O 10 11 12 m ΔvidG O O n ΔvidN H H o ΔvidO HO O HO OH O OH O OH 13 14 p ΔvidR New compounds 10.015.0 20.0 25.0 30.0 35.0 40.0 Retention time (min) Fig. 2 Metabolite analysis of the vid gene deletion mutants. a–p HPLC profiles of extracts from the vid gene deletion mutants. q Structures of the compounds isolated from the vid gene deletion mutants. The chromatograms were monitored with an evaporative light scattering detector (ELSD). The new compounds are indicated by red numbers furanosteroids should be adopted. Since demethoxyviridin pos- three clusters, and found that only in cluster V, all of the genes sesses a highly oxygenated structure, we inferred that there should including six CYP genes were upregulated under the demethox- be multiple cytochrome P450 monooxygenase (CYP) genes in its yviridin productive conditions (Supplementary Fig. 4). This result biosynthetic gene cluster. Thus, the CYP gene clusters in the was further confirmed by RNA sequencing (RNA-Seq), and the genome could be potential targets. To identify the biosynthetic genes from g3262 to g3284 were found to be upregulated, except gene cluster of demethoxyviridin, we sequenced the whole gen- for the non-expressed gene, g3263 (Supplementary Fig.
Recommended publications
  • The Influence of Adenoviral Infection and the Group VIA Calcium- Independent Phospholipase A2 on Hepatic Lipid Metabolism
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2007 The Influence of Adenoviral Infection and the Group VIA Calcium- Independent Phospholipase A2 on Hepatic Lipid Metabolism William Palmer Wilkins III Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Biochemistry, Biophysics, and Structural Biology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/1369 This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. © William Palmer Wilkins, III, 2008 All Rights Reserved THE INFLUENCE OF ADENOVIRAL INFECTION AND THE GROUP VIA CALCIUM-INDEPENDENT PHOSPHOLIPASE A2 ON HEPATIC LIPID METABOLISM A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University. by WILLIAM PALMER WILKINS, III Bachelor of Science, Hampden-Sydney College, 1996 Director: SUZANNE E. BARBOUR, PHD PROFESSOR, DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY Virginia Commonwealth University Richmond, Virginia MAY 2008 ii Acknowledgement I wish to thank my thesis advisor Dr. Suzanne Barbour for her consistent support, guidance and belief in my abilities as a scientist during my years of graduate study. I wish to acknowledge my mother Brenda Burke McGehee, father William Palmer Wilkins, Jr. and close friends for their support and encouragement throughout my life. I wish to thank the following committee members for their efforts during my training: Dr. Shobha Ghosh, Dr.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0186168 A1 Konieczka Et Al
    US 2016O1861 68A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0186168 A1 Konieczka et al. (43) Pub. Date: Jun. 30, 2016 (54) PROCESSES AND HOST CELLS FOR Related U.S. Application Data GENOME, PATHWAY. AND BIOMOLECULAR (60) Provisional application No. 61/938,933, filed on Feb. ENGINEERING 12, 2014, provisional application No. 61/935,265, - - - filed on Feb. 3, 2014, provisional application No. (71) Applicant: ENEVOLV, INC., Cambridge, MA (US) 61/883,131, filed on Sep. 26, 2013, provisional appli (72) Inventors: Jay H. Konieczka, Cambridge, MA cation No. 61/861,805, filed on Aug. 2, 2013. (US); James E. Spoonamore, Publication Classification Cambridge, MA (US); Ilan N. Wapinski, Cambridge, MA (US); (51) Int. Cl. Farren J. Isaacs, Cambridge, MA (US); CI2N 5/10 (2006.01) Gregory B. Foley, Cambridge, MA (US) CI2N 15/70 (2006.01) CI2N 5/8 (2006.01) (21) Appl. No.: 14/909, 184 (52) U.S. Cl. 1-1. CPC ............ CI2N 15/1082 (2013.01); C12N 15/81 (22) PCT Filed: Aug. 4, 2014 (2013.01); C12N 15/70 (2013.01) (86). PCT No.: PCT/US1.4/49649 (57) ABSTRACT S371 (c)(1), The present disclosure provides compositions and methods (2) Date: Feb. 1, 2016 for genomic engineering. Patent Application Publication Jun. 30, 2016 Sheet 1 of 4 US 2016/O186168 A1 Patent Application Publication Jun. 30, 2016 Sheet 2 of 4 US 2016/O186168 A1 &&&&3&&3&&**??*,º**)..,.: ××××××××××××××××××××-************************** Patent Application Publication Jun. 30, 2016 Sheet 3 of 4 US 2016/O186168 A1 No.vaegwzºkgwaewaeg Patent Application Publication Jun. 30, 2016 Sheet 4 of 4 US 2016/O186168 A1 US 2016/01 86168 A1 Jun.
    [Show full text]
  • Steroids: a Diverse Class of Secondary Metabolites Aeysha Sultan*And Abdul Rauf Raza Department of Chemistry, University of Sargodha, Sargodha-40100, Pakistan
    inal chem ic i d s Sultan and Rauf Raza. Med chem 2015, 5:7 e tr M y Medicinal chemistry DOI: 10.4172/2161-0444.1000279 ISSN: 2161-0444 Review Article Open Access Steroids: A Diverse Class of Secondary Metabolites Aeysha Sultan*and Abdul Rauf Raza Department of Chemistry, University of Sargodha, Sargodha-40100, Pakistan Abstract Steroids form a group of secondary metabolites having diversity in their structure and biological functions. These natural products, although often linked with the deleterious effect on health, have many medicinal applications and the research is still continued in search of these secondary metabolites as potential lead in drug design/discovery. The Aim of this review is to systematically compile the basic information related to this class of natural products. What are Steroids? 4. Fission of a ring, with addition of a hydrogen atom at each terminal group thus created, is indicated by the prefixseco , e.g., Steroids are a group of cholesterol derived lipophilic, low-molecular 2,3-seco-5a-cholestane 6. weight compounds found in / derived from a variety of different C6H13 OH marine, terrestrial, and synthetic sources. Steroid family includes the 17 H sterols, , bile acids [1-4], a number of hormones (both gonadal and 1 8 2 5 5 H H adrenal cortex hormones) and some hydrocarbons [5]. All steroid 3 6 4a O classes and their metabolites play important roles in the physiology and H 3 H 4 5 H 6 7 biochemistry of living organisms in which these are found. A number The stereochemistry of steroids reveals them to be non-flat of synthetic steroids are being extensively used as anti-hormones [6], molecules and the hexagonal carbon rings (A to C) usually assumes contraceptive drugs [7],anti-cancer agents [8]cardiovascular agents [9], a chair rather than a boat conformation.
    [Show full text]